Podcasts about sema4

Key Points From This Episode:Ram Venkatesh describes his career journey to founding Sema4.ai. The pain points he was trying to ease with Sema4.ai.How our general approach to big data is becoming more streamlined, albeit rather slowly. The ins and outs of Sema4.ai and how it serves its clients. What Ram means by “agent” and “agent agency” when referring to machine learning copilots.The difference between writing a program to execute versus an agent reasoning with it.  Understanding the contextual work training method for agents. The relationship between an LLM and an agent and the risks of training LLMs on agent data.Exploring the next generation of LLM training protocols in the hopes of improving efficiency. The requirements of an LLM if you're not training it and unpacking modality improvements. Why agent input and feedback are major disruptions to SaaS and beyond. Our guest shares his hopes for the future of AI. Quotes:“I've spent the last 30 years in data. So, if there's a database out there, whether it's relational or object or XML or JSON, I've done something unspeakable to it at some point.” — @ramvzz [0:01:46]“As people are getting more experienced with how they could apply GenAI to solve their problems, then they're realizing that they do need to organize their data and that data is really important.” — @ramvzz [0:18:58]“Following the technology and where it can go, there's a lot of fun to be had with that.” — @ramvzz [0:23:29]“Now that we can see how software development itself is evolving, I think that 12-year-old me would've built so many more cooler things than I did with all the tech that's out here now.” — @ramvzz [0:29:14]Links Mentioned in Today's Episode:Ram Venkatesh on LinkedInRam Venkatesh on XSema4.aiClouderaHow AI HappensSama

Despite advancements in genetic testing, people with rare diseases often face a prolonged diagnostic odyssey involving multiple physician visits and misdiagnoses. Genetic testing company GeneDX is working to shorten the path to a diagnosis by expanding access to sequencing, collaborating with researchers, and accumulating data to better understand gene-disease relationships. We spoke to Katherine Stueland, CEO of GeneDx, about the state of genetic testing, what its 2022 acquisition by the AI-drive genomics company SEMA4 has meant to it, and what she thinks it will take to make meaningful change to the diagnostic odyssey.

Rob Bearden's journey is one of innovation, leadership, and relentless pursuit of growth. From his early days at Oracle to his most recent venture, Sema4.ai, Rob has been at the forefront of technological transformation across multiple industries. In this exclusive interview, Rob dives into his experiences, the lessons he learned when building and scaling his companies, and the vision that drives his latest endeavor. Rob's company, Sema4.ai, has attracted funding from top-tier investors like Benchmark (Business/Productivity Software), Mayfield Fund, Canvas Ventures, Harpoon VC, and Uncorrelated Ventures.

The Shred is a weekly roundup of who's raised funds, who's been acquired and who's on the move in the world of recruitment. The Shred is brought to you today by Jobcase.

As the summer was ending,I sat down with Isaac Ro, Life Sciences Executive, who I originally met at the Blue Genes Bash several years ago.  Isaac left Goldman Sachs for Thrive Early Detection, where Bert Vogelstein and the group were working on liquid biopsy.  After Thrive was acquired by Exact Sciences, Isaac left and became CFO at Sema4, which was a company where I worked as well.  After taking Sema4 public, Haystack oncology is his newest venture which works on MRD in cancer.  We talk data, the financial climate in genetics, and what it's like to pivot to a management role where you're relying on everyone in the team for company success.     

Last week, during the first International Conference on Newborn Sequencing, a landmark study to sequence the genomes of 100,000 newborns was announced. Called the GUARDIAN study, the project is the brainchild of Wendy Chung, Professor of Pediatrics at Columbia University. The study will take place in New York State and is somewhat similar to an ongoing project in the U.K. being done by Genomics England.

Todd is joined by GOP Gubernatorial Candidate Bob Stefanowski to take calls from voters on plenty of topics from abortion, SEMA4, his campaign, and more. Tune in 3-6 PM EST weekdays on WTIC NewsTalk 1080; or on the Audacy app!

Todd is joined by George Colli of GColli.com to expand on the recent press from Ned Lamont, and the stark response from Ned, as he continues to be pressed on SEMA4 and the CT state no-bid contracts. Todd then breaks down the news around Trump his colleague Weisselberg pleading guilty. Tune in 3-6 PM EST weekdays on WTIC NewsTalk 1080; or on the Audacy app!

Happy Pride month! This episode we are continuing our celebrations! Last episode (#189) we interviewed two experts from PhenoTips, Orion Buske and Erica Peacock about building inclusive pedigrees. This episode is a fantastic follow up about how to provide gender affirming care, specifically in the genetic counseling space. As a queer member of the LGBTQIA+ community, our host Kira Dineen is excited to share this episode.DNA Today's host Kira Dineen is also one of the hosts of the PhenoTips Speaker Series. This monthly live webinar focuses on relevant genetics topics by featuring discussions with thought leaders and experts in genomic medicine. This episode is the 20th installment of the PhenoTips' Speaker Series, “Gender Affirming Care in Genetic Counseling”.The webinar is sponsored by PhenoTips. During these live events we interview leaders in the field of genetics and moderate questions live from the audience. Check out upcoming installments by heading over to PhenoTips.com where you can also stream all the webinars from the last two years. Gender Affirming Care in Genetic Counseling is a panel discussion and interactive Q & A with host and genetic counselor Kira Dineen, diversity and inclusion advocate and hereditary cancer genetic counselor at Genome Medical, Joanna Mercado, prenatal genetic counselor at Sema4, Marney Brillinger, and transgender patient advocate, Holden Bender-Bernstein.Cultural attitudes towards the transgender community have shifted in recent years, allowing trans individuals to become more visible and empowered than previously possible. As the trans population grows in response, so too do health disparities and incidents of transphobia experienced by this historically medically marginalized group. With no agreed-upon pedigree standards for trans individuals and limited cultural competency training, genetic counselors face significant challenges providing the necessary affirming care to transgender and gender non-conforming patients.On This Episode We Discuss:• Improving clinic experiences for transgender and gender non-conforming patients• Beyond standards: gender affirming family history collection• Challenges to providing gender affirming care in existing service delivery models• Education and advocacy in the genetics and genomics communityThe PhenoTips Speaker Series is also available now as a podcast, so search “PhenoTips Speaker Series” wherever you are listening to this podcast (Apple, Spotify) to subscribe and stay updated on new episodes. Stay tuned for the next new episode of DNA Today on July 1st, 2022! New episodes are released on Fridays. In the meantime, you can binge over 190 other episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Today”. Episodes since 2021 are also recorded with video which you can watch on our YouTube channel. DNA Today is hosted and produced by Kira Dineen. Our social media lead is Corinne Merlino. Our video lead is Amanda Andreoli. See what else we are up to on Twitter, Instagram, Facebook, YouTube and our website, DNApodcast.com. Questions/inquiries can be sent to info@DNApodcast.com. PerkinElmer Genomics is a global leader in genetic testing focusing on rare diseases, inherited disorders, newborn screening, and hereditary cancer. Testing services support the full continuum of care from preconception and prenatal to neonatal, pediatric, and adult. Testing options include sequencing for targeted genes, multiple genes, the whole exome or genome, and copy number variations. Using a simple saliva or blood sample, PerkinElmer Genomics answers complex genetic questions that can proactively inform patient care and end the diagnostic odyssey for families. Learn more at PerkinElmerGenomics.com. (SPONSORED)HemoShear Therapeutics is a clinical stage company developing new treatments for patients with rare metabolic disorders. By partnering with fellow biopharma companies, HemoShear is accelerating their drug discovery and development programs in metabolic disorders, and also liver diseases and gout. HemoShear is currently conducting a clinical trial for a new therapy for propionic and methylmalonic Acidemia. Learn more about these conditions and the clinical trial in an upcoming episode of DNA Today! You can also visit hemoshear.com. (SPONSORED)In my free time during the summer I am usually with friends at our apartment's pool. My spot is right next to the water reading a book, most recently “A Crack In Creation”, which might come up in a future episode. I like keeping cool by sipping on some ice tea while I read, but I don't like all the sugar. So I've been enjoying Sound drinks instead. Sound makes unsweetened, organic sparkling waters made with tea and botanicals. No natural flavors or sugar. My fav is the blueberry with cinnamon and hibiscus tea. Try it out by ordering at DrinkSound.com using promo code DNATODAY for 20% off! Plus you are supporting the podcast. (SPONSORED)A bunch of my friends at my apartment have dogs and I love being able to offer them a treat when I take them for a walk or when they visit my place. So I got Sundays for Dogs. Now this is dog food, but can also be used as dog treats. My friend Annie's dog, Frank, gets so excited when he sees me, and if I'm being honest, I think it's more the food than me. Sundays For Dogs is real food formulated by a Vet with high quality meat, veggies, fruit and superfoods, then air-dried to perfection. Since you are a DNA Today listener, you can visit SundaysForDogs.com and use code “DNATODAY” for 35% off your first order. Support your pup and the podcast! (SPONSORED)

Todd opens the show breaking down some rants of the weekend, with comments on the tragic shooting, inflation, gas prices, and baby formula. Todd then is joined by George Colli of GColli.com to speak on his latest insight around Lamont and SEMA4, as well as his new website feature "The G List". Tune in weekdays 3-6 PM EST on WTIC Newstalk 1080 ;or on the new Audacy app!

Dr. George Emanuel shares about single-cell spacial genomics in this podcast episode. Dr. Emanuel is the Scientific Cofounder and Director of Technology and Partnerships at Vizgen, a biotechnology company that is dedicated to pioneering the next generation of spatially resolved transcriptomics profiling tools to provide new insight into the biological systems that underlie human health and disease. Spatial genomics is a new frontier in molecular biology, which aims to assay the genomic information of single cells within their native tissue environment, combining spatial transcriptomics with single-cell sequencing. This exciting technology was named Nature's "Method of the Year 2020"!Dr. Emanuel has spent the past decade developing high-throughput spatial profiling technologies including extending Vizgen's MERFISH (Multiplexed Error-Robust Fluorescence in situ Hybridization) technology to profile 10,000 genes in the same sample. He received dual undergraduate degrees from the University of Colorado, and a Ph.D. in Biophysics from Harvard University.On This Episode We Discuss:Single-cell spatial genomicsDifference between sequencing genes and analyzing spatial gene expressionInsight for researchers through gene expression analysisMERFISH & MERSCOPELimitations of the testingAreas of research that MERFISH can be applied toHow can researchers get access to a MERSCOPE PlatformIf you're interested in learning more about Vizgen's technology, visit their website to play around with the MERSCOPE Vizualizer, and check out their papers on mapping the brain and how MERFISH was demonstrated on 10,000 genes.Keep up to date with the latest developments at Vizgen by following them on Twitter, Facebook, and LinkedIn, and connect with our guest, Dr. George Emanuel on Linkedin!Stay tuned for the next new episode of DNA Today on April 8, 2022 where our host, Kira Dineen, will be on the other side of the mic. She will be interviewed by James Fodor of The Science of Everything Podcast about genetic testing. New episodes are released on Fridays. In the meantime, you can binge over 175 other episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Today”. Episodes since 2021 are also recorded with video which you can watch on our YouTube channel. DNA Today is hosted and produced by Kira Dineen. Our social media lead is Corinne Merlino. Our video lead is Amanda Andreoli. See what else we are up to on Twitter, Instagram, Facebook, YouTube and our website, DNApodcast.com. Questions/inquiries can be sent to info@DNApodcast.com. PerkinElmer Genomics is a global leader in genetic testing focusing on rare diseases, inherited disorders, newborn screening, and hereditary cancer. Testing services support the full continuum of care from preconception and prenatal to neonatal, pediatric, and adult. Testing options include sequencing for targeted genes, multiple genes, the whole exome or genome, and copy number variations. Using a simple saliva or blood sample, PerkinElmer Genomics answers complex genetic questions that can proactively inform patient care and end the diagnostic odyssey for families. Learn more at PerkinElmerGenomics.com. (SPONSORED)Polygenic risk scores (or PRS) are a powerful way to identify an individual's risk of common disease by analyzing up to millions of genetic variants spread across the genome. Allelica has launched the first PRS test on the market to calculate ancestry-specific PRS for breast cancer, prostate cancer, coronary artery diseases, Type 2 Diabetes and Alzheimer's disease and deliver the results in a clinical-grade report. Order your test today at order.allelica.com. For 25% off AND free shipping, use code “DNATODAY” at checkout. Allelica: Empowering the next generation of clinical genomics. Check out Allelica' interview about PRS with co-Founder and CEO Giordano Bottà on Episode #168 of “DNA Today”! (SPONSORED)Sema4 offers an extensive portfolio of health information solutions, including pre-clinical and clinical trial support, analytics for actionable insights, and advanced sequencing services. Sema4's family of precision oncology products and services, Sema4 Signal®, provides data-driven care solutions with advanced analytics, digital tools, and exome-based somatic and hereditary cancer genomic tests. Learn more about their mission at Sema4.com. Sema4, a patient-centered health intelligence company. (SPONSORED)

@AviNMash and @AnthonyOhayon discuss if it is time to feel bullish? What happened with Tesla Split? Are AMC and GME about to go round 2? Gingko Bioworks and Sema4 might not suck anymore? $SHOP $GME $AMC $TSLA $DNA $SMFR $BTC $ETH Huge shout out to our sponsors at StockTwits our favorite place to get a pulse of what people are saying about our favorite ticker symbols in both Stocks and Crypto www.StockTwits.com

In this episode, Dr. Cuesta chats with Dr. Gustavo Stolovitzky, a thought leader in the realm of computational biology and a pioneer in the realm of precision medicine. Gustavo was the director of IBM's translational systems biology and nanobiotechnology program, an adjunct professor at both the Icahn School of Medicine and Columbia University, and is currently the Chief Scientific Officer at Sema4, a data-driven precision medicine company. We discuss:What is precision medicine: the historical and conceptual origins as well as the direction the field is moving todayHow the synergy of artificial intelligence and advancements in synthetic biology are enabling precision medicineObstacles in artificial intelligence and how they are impeding the growth of precision medicineUsing deep learning in medicine: supervised learning, explainable AI, and overfitting algorithms The DREAM challenges and how crowdsourcing solutions in computational biology can help solve issues in precision medicineHow will AI fit into the clinical landscapeSema4 and how data is translated from concept to clinical practiceIntellectual property and how to protect your algorithms in precision medicineWhat is the best path to break into precision medicine

Today, we hear about an 80 year tradition at the Bethlehem Connecticut post office that has earned it the nickname Christmastown. Thousands of cards and packages come through this tiny post office every year to get one of their cachets. On Friday, the Connecticut Mirror reported that Sema4, the laboratory based in Stamford responsible for managing 15 out of the 23 state testing sites, has pulled out of it's contract with the state. The company will exit the testing business by mid-January. With the holidays coming up and latest surge in cases, this could not have come at a worse time. Connecticut Mirror investigative reporter Dave Altimari joins us. And later, the Connecticut Social Equity Council is working to set the criteria for those that want to open an adult-use marijuana business on the state. We'll also hear from Andrea Comer, the Social Equity Council Committee Chairwoman. GUESTS: Dave Altimari - Investigative Reporter at Connecticut Mirror Vera Rosa - retired postal clerk of the Bethlehem Post Office Andrea Comer - Interim Deputy Commissioner for the Department of Consumer Protection and the Social Equity Council Committee Chairwoman Support the show: http://wnpr.org/donate See omnystudio.com/listener for privacy information.

Todd breaks down more from these stories before airing the rant hour, with topics ranging from Lamont, to CT legislation, and even some feedback regarding the vaccine. Todd then is joined by George Colli of GColli.com to speak on his perspective regarding the breaking news on SEMA4 leaving the state of Connecticut. Tune in weekdays 2-6 PM EST on WTIC Newstalk 1080 ;or on the new Audacy app! See omnystudio.com/listener for privacy information.

Todd opens the show breaking down the big stories of the day, which includes a piece from the Courant on Blumenthal regarding his appearance at the event for the Connecticut Socialist Party, as he claims to be unaware of the nature of the group. Todd then breaks down a piece from the CT Mirror regarding Ned Lamont and SEMA4 as they have pulled out of CT for COVID testing as the pressure mounts for Gov Lamont. Tune in weekdays 2-6 PM EST on WTIC Newstalk 1080 ;or on the new Audacy app! See omnystudio.com/listener for privacy information.

Todd is first joined by Pat Sasser for his thoughts on Lamont and his current path moving into an election year, compounding with his controversy around SEMA4 and his wife Annie. Todd then dives into the rants with topics on Traffic Cams, Todd's views, Lamont, Biden, and more. Todd then speaks with Michael Liebowitz on Capitalism as well as reacting to some of the day's interview's. Tune on weekdays 2-6 PM EST on WTIC Newstalk 1080 ;or on the new Audacy app! See omnystudio.com/listener for privacy information.

Todd opens the hour joined by George Colli of GColli.com to speak on the continued controversy surrounding the Lamont's and their involvement in SEMA4 as well as the new Digital Currency Group. Todd and George break down the inconsistency in the argument to have financial interests and the issue with the lack of transparency from the Lamont's. Todd and George take some callers on the issue as well. Tune in weekdays 2-6 PM EST on WTIC Newstalk 1080 ;or on the new Audacy app! See omnystudio.com/listener for privacy information.

Todd opens the program joined by Chris Powell to speak on the latest in regards to Juvenile Crime, and the constant spinning of criminal acts to continually protect the inept democratic power structure, and the failed system seen in CT. Todd then is joined by Len Suzio to break down the developing controversy around Lamont and his wife as journalists start to press the Governor on possible conflicts with SEMA4 as well as the DCG currency group. Tune in weekdays 2-6 PM EST on WTIC Newstalk 1080 ;or on the new Audacy app! See omnystudio.com/listener for privacy information.

Todd speaks on the controversy around Ned and Annie Lamont as the plot continues to thicken with the involvement in Sema4 and now Digital Currency Group. Then, Todd is joined by Reese Hopkins to speak on his thoughts regarding the Cuomo brothers, and his outlook with the developing Alec Balwin case regarding the prop gun and his film “Rust”. Tune in weekdays 2-6 PM EST on WTIC Newstalk 1080 ;or on the new Audacy app! See omnystudio.com/listener for privacy information.

SEMA4 and other questions

Understanding opportunities available to us all

George Colli joins us for an update on his investigation into Sema4, the Stamford company whose no bid contract with the state, combined with an investment in Sema4 from Annie Lamont's hedge fund, has led to an appearance of unseemliness that begs for transparency. Then, Len Suzio is here to explain why Ned's new gas tax is way worse than just another gas tax. See omnystudio.com/listener for privacy information.

As the Russell 2000 surges to a new record high, Scott Wapner and the Investment Committee discuss why that’s a very positive sign for your money. Plus, we highlight yet another big wall street name announcing a sizable SPAC deal today.  Keith Meister and Eli Casden join us to describe their new merger of CM Life Sciences with the healthcare company SEMA4.  

James Coffin, PhD, President and Chief Operating Officer at Sema4, a patient-center health intelligence digital company, discusses the new ability of the company to handle up to 15,000 COVID-19 viral and 4000 antibody tests a day with 24 hour turnaround for COVID and 48 for the antibody test. He talks about how Sema4 is working directly with higher education, assisting government and large businesses to get students, staff, and workers back to school and work safely. There is also Sema4 Works, an app that enables symptom tracking through simple self-reporting of symptoms by registered individuals.

We get the Businessweek Agenda with Bloomberg Intelligence Chief Equity Strategist Gina Martin Adams and Bloomberg Stocks Editor Dave Wilson. Dr. Eric Schadt, CEO at Sema4, discusses the inefficiency of virus testing and how labs can improve. Bloomberg Businessweek Editor Joel Weber and Bloomberg News P&I Reporter Vernon Silver share their insight on how vaccine nationalism will only make the coronavirus pandemic worse. Bloomberg News Sustainability Editor Emily Chasan talks about why long-term investors now hold more sway over ESG. And we Drive to the Close with Brian Yacktman, Chief Investment Officer at YCG Investments. Host: Carol Massar and guest co-host Alix Steel. Producer: Doni Holloway.  

We get the Businessweek Agenda with Bloomberg Intelligence Chief Equity Strategist Gina Martin Adams and Bloomberg Stocks Editor Dave Wilson. Dr. Eric Schadt, CEO at Sema4, discusses the inefficiency of virus testing and how labs can improve. Bloomberg Businessweek Editor Joel Weber and Bloomberg News P&I Reporter Vernon Silver share their insight on how vaccine nationalism will only make the coronavirus pandemic worse. Bloomberg News Sustainability Editor Emily Chasan talks about why long-term investors now hold more sway over ESG. And we Drive to the Close with Brian Yacktman, Chief Investment Officer at YCG Investments. Host: Carol Massar and guest co-host Alix Steel. Producer: Doni Holloway.   Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Today on Health in 2 Point 00, Jess helps Matthew to celebrate his birthday Kylie Jenner-style. On Episode 140, Jess and Matthew discuss Humana investing $100 million in Heal, Lemonaid raising $33 million in a Series B, CVS Caremark announcing 5 new companies in their digital health platform—4 of which are about weight loss, and perplexing health intelligence company Sema4 raising $121 million in a seed round.

Dr. Eric Schadt, CEO at Sema4, discusses providing COVID-19 testing for the State of Connecticut. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Senior Writer Shelly Banjo share their insight on how the pandemic has disproportionately impacted working women. We get Businessweek Economics with Bloomberg Senior U.S. Economist Yelena Shulyatyeva. Bloomberg News Sustainability Editor Emily Chasan talks about ways electric vehicle makers can continue pre-pandemic momentum. And we Drive to the Close with Michael Sheldon, Chief Investment Officer at Hightower RDM. Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway. 

Dr. Eric Schadt, CEO at Sema4, discusses providing COVID-19 testing for the State of Connecticut. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Senior Writer Shelly Banjo share their insight on how the pandemic has disproportionately impacted working women. We get Businessweek Economics with Bloomberg Senior U.S. Economist Yelena Shulyatyeva. Bloomberg News Sustainability Editor Emily Chasan talks about ways electric vehicle makers can continue pre-pandemic momentum. And we Drive to the Close with Michael Sheldon, Chief Investment Officer at Hightower RDM. Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.  Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

On this week’s Tech Nation, Dr. Eric Schadt, the Founder & CEO of Sema4 talks about the explosion of personal medical information, and how it could work for us in the future. Then on Tech Nation Health, work on a vaccine to treat Alzheimer’s … and potentially prevent it. Dr. Ajay Verma, Chief Medical Officer of United Neuroscience tells us how and why it might work. Then Chief Correspondent Dr. Daniel Kraft talks about The Age Wave.

On this week’s Tech Nation, Dr. Eric Schadt, the Founder & CEO of Sema4 talks about the explosion of personal medical information, and how it could work for us in the future. Then on Tech Nation Health, work on a vaccine to treat Alzheimer’s … and potentially prevent it. Dr. Ajay Verma, Chief Medical Officer of United Neuroscience tells us how and why it might work. Then Chief Correspondent Dr. Daniel Kraft talks about The Age Wave.

On this week’s Tech Nation, Dr. Eric Schadt, the Founder & CEO of Sema4 talks about the explosion of personal medical information, and how it could work for us in the future. Then on Tech Nation Health, work on a vaccine to treat Alzheimer’s … and potentially prevent it. Dr. Ajay Verma, Chief Medical Officer of United Neuroscience tells us how and why it might work. Then Chief Correspondent Dr. Daniel Kraft talks about The Age Wave.

On this week’s Tech Nation, Dr. Eric Schadt, the Founder & CEO of Sema4 talks about the explosion of personal medical information, and how it could work for us in the future. Then on Tech Nation Health, work on a vaccine to treat Alzheimer’s … and potentially prevent it. Dr. Ajay Verma, Chief Medical Officer of United Neuroscience tells us how and why it might work. Then Chief Correspondent Dr. Daniel Kraft talks about The Age Wave.

Why do I need genetic carrier screening? What does it mean to be a genetic carrier? What diseases are you at risk of passing along to your child? These questions and more will be answered and discussed in this episode of Focus on Fertility as we are joined by genetic counselor, Jennifer Siegel, of Sema4. Your genes and those of your partner will lead to the DNA makeup of your off-spring. What is inside yours and your partner’s genes could greatly impact the health of your child and knowing what’s inside of these genes is crucial.

Britt Wray and Ellie Cosgrave take a deep dive into our data. They discuss the implication of personal data rights in everything from city planning to medicine to human rights. You'll hear from: Paul-Olivier Dehaye, who testified in the Cambridge Analytica case; Ravi Naik, the solicitor from ITN Solicitors taking on Cambridge Analytica; Martha Lane Fox CBE, founder of the think tank Doteveryone; digital sociologist and strategist Lisa Talia Moretti; Francesca Bria, the chief Technology and Digital Innovation Officer for the City of Barcelona; Eric Schadt, Founder and CEO of Sema4 and expert in big data and medicine; Judith Deportail, data journalist; Jamie Bartlett, author of 'People vs Tech' and Director for The Centre for the Analysis of Social Media at Demos; Michael Veale, researcher in responsible public sector machine learning at University College London; and Edina Harbinja, senior lecturer in law, University of Hertfordshire.

While breakthroughs in the ability to diagnose newborns with genetic diseases continues to expand in scope and fall in cost, the extent of newborn screening varies state-by-state. Nevertheless, the improving affordability of newborn screening is expanding access to these tests for parents seeking them. We spoke to Eric Schadt, CEO of Sema4, about the changing landscape for newborn screening, the company’s Natalis test, and how far off we are from routine screening of newborns with comprehensive genetic sequencing.

"We like to refer to it as consumer initiated, but physician supervised,” says Eric Schadt today when asked if his new test is direct-to-consumer. Eric is the Dean for Precision Medicine at the Icahn School of Medicine at Mount Sinai in New York and since 2016 has served as CEO of Sema4, a spinoff that he founded out of the Mount Sinai Health System. Sema4 launched a newborn screening panel, Sema4 Natalis, in February of this year covering over 190 disorders.

Eric Schadt may enjoy the simple things in life — high velocity, a good polo shirt — but he is the first to admit that life is not simple. Living things are such complex systems, in fact, that our best chance to promote wellness is to understand them as vast information networks. To do so, Eric is unleashing maximum scale and bringing the firepower of math to bear. He endeavors to monitor and modify humans-slash-networks, both as CEO of the new genomics startup Sema4, and as Dean for Precision Medicine at the Icahn School of Medicine at Mt. Sinai. This episode was recorded in front of a live audience, on location - outdoors no less - at the Foundation2017 conference. Make of it what you will: as soon as Eric discussed god, the birds start chirping.

In Episode 15 of Hidden Forces, host Demetri Kofinas speaks with Dr. Eric Schadt. Eric Schadt is founder and CEO of Sema4, as well as Dean of Precision Medicine at the Icahn School of Medicine at Mount Sinai. During the course of his 20-year career, Dr. Eric Schadt has built genetics and systems biology groups at Merck. He built the computational biology group at Rosetta. He has served as co-founder of Sage Bionetworks and as Chief Science Officer of Pacific Biosciences. He now serves as the founder and CEO of Sema4. He has published more than 300 peer-reviewed papers in leading scientific journals, and he has contributed to a number of discoveries relating to the genetic basis of common human diseases such as diabetes, obesity and Alzheimer’s. In today’s conversation, we explore the information technology of biology – DNA – the world of genomics, where big data looms large. We begin by mapping the territory of the human genome and exploring the pathways of disease. We look to understand the ways in which complex genetic combinations express themselves as phenotypes such as height, bone structure, intelligence, and personality. How are these traits coded for? What are the instructions our body uses to repair a damaged cell? What blueprint does it consult before trying to grow new arteries? How does it know to regulate our appetite or when start us down the path of puberty? What happens when these instructions are damaged? How can the smallest difference in the order of life’s code make all the difference for our success, our happiness, and even our survival? 50 years have passed, between the discovery of the double-helix and the mapping of the first human genome. What progress have we made in the 15 years since? How has our ability to sequence new genomes created a paradigm shift in medicine? What is the role of big data and artificial intelligence in finding the correlations needed in order to treat malignancies and prevent diseases? What is the promise of genomics? What are the perils of big data in medicine? What stands between us and some superhuman future? Producer & Host: Demetri Kofinas Editor & Engineer: Stylianos Nicolaou Join the conversation on Facebook, Instagram, and Twitter at @hiddenforcespod

Robots are taking our jobs with J.P. Gownder of Forrester Research. Kali Thomas of the Providence VA Medical Center on music as mental medication for the elderly. Eric Schadt, CEO of Sema4 on fighting disease with DNA. Diane Gromala of Simon Fraser University on chronic pain relief through virtual reality. Newbery Awards with Gene Nelson, Director of Provo City Library. Documentary "Bannon's War" with Gabrielle Schonder, producer for Frontline.

ELEKTRODOS show of the 7th December 2015, dedicated to new electro songs from producers, such as Popkomm, Fleck ESC, Sematic4, DJ HasH, Juan Del Rio, Docta Gee and Diodes Vema-Roid. With DJ Set from Spy The Bandit ELEKTRODOS show del 7 de diciembre del 2015, dedicado a novedades de artistas como Popkomm, Fleck ESC, Sema4, DJ HasH, Juan Del Rio, Docta Gee and VeMa-Diodes. Con DJ Set de Spy aka The Bandit Tracklist: 01. Popkomm - Diva 02. Fleck E.S.C. - Slime Master 03. Sematic4 - Kalte Abend 04. Docta Gee - 308 05. Juan Del Rio - Play Wave Of Convex Surf 06. DJ HasH - Underground City 07. Vema Diodes - Bass Junkie 08. Spy aka The Bandit DJ Set Spy DJ Set Tracklist: 1.The Advent - The Faze 2.Palms Trax - late Jam 3.Plant 43 - Hydro Subway 4.Deemphasis - Hypnosis (Mental mix) 5.Umwelt - Perception Of The Heaven 6.Kima - Dinamico 7.Arcanoid - Force Of Gravity 8.Negocius Man - Microbiotech 9.Transparent Sound - Etincelle 10.Supreme Ja - Letters 11.Dez Williams - Reach The Void 12.Alavux - Ambience 13.Exzakt - Second Wave 14.Roid - Frozen Home 15.Umwelt - Guns Of The City 16.D.O.H.- Run With It 17.The Tyrell Corporation - Togheter Alone

ELEKTRODOS show of the 30th November 2015, dedicated to new electro songs from producers, such as DJ HasH, Juan Del Rio, Cybereign, Daisuke Sigimoto, AE35, Vertical Invader, K-Tanaka, Sema4 and Elektridas. With DJ Set from The Zenobit3 aka Sumerian Slave ELEKTRODOS show del 30 de noviembre del 2015, dedicado a novedades de artistas como DJ HasH, Juan Del Rio, Cybereign, Daisuke Sigimoto, AE35 , Vertical Invader, K-Tanaka, Sema4 y Elektridas.. Con DJ Set de Zenobit3 Tracklist: 01. DJ HasH - The Age Of The Synthezisers 02. Juan Del Rio - Analiza 03. Cybereign - U.M. World 04. Cybereign - Destiny 05. Daisuke Sugimoto - Graceful Moon (AE35 Remix) 06. Vertical Invader - Sun Rise On Mars 07. Vertical Invader - Martian Battleship At War 08. K-Tanaka - Input 09. Sematic 4 - Chase Scene 10. Sematic 4 - Neo-Tokio 11. Elektridas - Love Is The Peace (Love Anthem Remix) 12. The Zebonit3 DJ Set

Each show I ask an electronic music producer to select some tracks that are important to them: (1) Track/s that influenced their starting to make music (2) Track/s that have blown them away recently (3) Their favourite own production(s) This week - Interview & Mix from ACHIM.BLOCH, France First broadcast - 21st November 2014 Part 1 Illektrolab & 4th Genome - Bass Agenda Intro Achim.Bloch - Bipolar Bears Achim.Bloch - How We've Learned Russian With Funky Soul Achim.Bloch - The Kid in a Loophole With a Gamepad Achim.Bloch - Death of a Jobless Gamer Achim.Bloch - Growlings in a Neko Cafe Trisomie 21 - Jakarta Coil - Ostia (The Death of Pasolini) Plaid - Hawkmoth Esplendour Geometrico - Regeneracion Achim.Bloch - Aspartame Induced Seizure (Great Expectations) Achim.Bloch - Binary Achim.Bloch - Mexican Theory Obergman - Rosetta Plant43 - Emerald Abyss Dez Williams - Silver Phish Part 2 - guest mix by SEMA4 Anthony Rother - Human Made Hardfloor (feat. ERP)- You Know The Score ERP - Tuga Sync 24 - We Answer Sema4 - She Is A Replicant Signal Type - B-14 Anthony Rother - La Bete The Advent - Ekonomik Boris Divider (Umwelt rmx)- Evolution Sema4 - Nightdrive I-F - Spaced Invaders Are Smoking Grass Detroit Grand Pubahs - Sandwiches Abstract Tought - Synchronised Dimensions Dry Kru - Irgumburgum

Bastard Jazz Radio's DJ DRM & Sema4 return with another episode packed to the gills with brand new sounds and some classic joints you might have forgotten about.

Bastard Jazz Radio's DJ DRM and Sema4 finally reunite for a joint Best of 2012 show, featuring 12 tracks from across the board you may have missed in all he other "Best Of" lists from the year.

Bastard Jazz Radio's DJ DRM and Sema4 are finally back with a brand new episode of sweet treats and even deeper beats. Brand new material from Wagon Christ, Slow Hands, Erodiscotechque, Com Truse, The Revenge, DJ Dus, Ancient Astronauts, Lone and more....